Albatera, Lovely Jane .
HRN: 18-66-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2025
03/31/2025
IV
500mg
TID
T/C Incomplete Abortion
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes